Hyperglycemia is a marker for poor clinical outcome and mortality in hospitalized patients. In the critical care setting, insulin administered intravenously or subcutaneously is effective.

Of the 419 subjects screened, 328 were randomized to a treatment group. In the inhaled insulin group, 1 subject allocated to inhaled insulin was never treated; thus, 327 subjects received the ...

Keep abreast with the latest news related to Optimal Management of Basal-bolus Insulin Regimen there are 2873 news items on Optimal Management of Basal-bolus Insulin Regimen that covers updates ...

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...

Purpose. The efficacy and safety of and key clinical considerations for using U-500 insulin human regular in the treatment of high-dose insulin-treated patients in a wide variety of settings are ...

COPENHAGEN, Denmark & PALO ALTO, Calif.--(BUSINESS WIRE)--Glooko, Inc. and Hedia today announced the launch of their interoperable solution, which combines connected care, remote patient ...

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN, Denmark and PALO ALTO, Calif.